Chris Price Joins Oak HC/FT as Venture Partner

January 18, 2022

Established healthcare investor will expand Oak HC/FT’s strong and growing bench of experts

Brings significant entrepreneurial experience to companies transforming the healthcare industry

Greenwich, Connecticut (April 27, 2016) Oak HC/FT, a leading venture growth-equity fund, announced today the appointment of Chris Price as Venture Partner. He is the latest of several industry experts to join the venture firm, which invests in healthcare information and financial technology companies.

“Chris is a talented entrepreneur and investor with diverse healthcare expertise, particularly in the areas of pharmaceutical management and distribution, digital health and care management,” said Andrew Adams, General Partner at Oak HC/FT. “He understands the opportunities and dynamics shaping the healthcare marketplace and will bring significant experience to our team and to our growing portfolio of companies. We are excited to welcome him and to leverage his unique background.”

“Oak HC/FT has a peerless reputation in the healthcare information and services sector,” said Chris Price. “I look forward to working with their team to identify the next generation of entrepreneurs who will drive growth and innovation in the healthcare sector.”

During his career, Chris has led or played a significant role as an executive, investor or advisor to transactions representing over $4 billion in aggregate value. Most recently he was a senior vice president at ADVI Health, a healthcare advisory firm focused on the life sciences, digital health, managed care and services sectors. At ADVI he assisted clients with corporate and product development strategy development and execution.

Chris previously served as a senior vice president for strategy and product at EnvisionRx, a pharmacy benefit manager with over $4 billion in revenue. He is also a former managing partner and founder at Broad Creek Partners, which focused on tech-enabled health care services investment and advisory where he led the carve-out and sale of RegenceRx to Catalyst Health for Cambia Health Solutions.

About Oak HC/FT

Oak HC/FT ( is the premier venture growth-equity fund investing in Healthcare Information & Services (“HC”) and Financial Services Technology (“FT”). We are focused on driving transformation in these industries by providing entrepreneurs and companies with strategic counsel, board-level participation, business plan execution and access to our extensive network of industry leaders.

Media Contact:

Samantha Nelson, 917-482-9989,